GAD-tolerizing vaccine (Diabetology)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGAD-tolerizing vaccine (Diabetology)
Drug Alias Nameglutamic acid decarboxylase-tolerizing vaccine (Diabetology)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionGlutamate decarboxylase modulators
TargetsGlutamate decarboxylase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiabetology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiabetology Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A